85332657
May 27, 2011
Oral liquid suspension pharmaceutical preparations for the extended relief of central nervous system diseases and disorders and for the treatment of attention deficit hyperactivity disorder; methylphenidate hydrochloride in oral suspension liquid form for the extended relief of central nervous system diseases and disorders and for the treatment of attention deficit hyperactivity disorder
Pharmaceuticals